Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.

Seattle Genetics (NASDAQ: SGEN)

SGEN 166.22
2.94 (1.7%)

Open: 168.98 High: 170.53 Low: 165.48


External Links

52WL $134.01

The 52 Week Low is $134.01 set on Wed, May 5, 2021.

52WH $213.94

The 52 Week High is $213.94 set on Tue, Oct 13, 2020. The current price, $166.22, is 22% below the 52 Week High.

ATH $213.94

The All-Time High is $213.94 set on Tue, Oct 13, 2020. The current price, $166.22, is 22% below the All Time High.

52 Week Range

May 5, 2021
Oct 13, 2020

SGEN Earnings

Q1 Earnings for Jan, Feb & Mar

Thu, Apr 29, 2021

Since Q1 Earnings Report

SGEN 15.0%

Q2 Earnings for Apr, May & Jun

Thu, Jul 29, 2021

Since Q2 Earnings Report

SGEN 13.8%

SGEN Profile

Seattle Genetics trades on the NASDAQ. SGEN's market cap is 30.3 Billion.

Seagen Inc. (formerly known as Seattle Genetics) is a biotech firm that develops and commercializes therapies to treat cancers. Seagen's therapies are based on antibody-drug conjugate technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, Adcetris, has received approval for six indications to treat Hodgkin lymphoma and T-cell lymphoma. Other approved products include Padcev for bladder cancer and Tukysa for breast cancer. The company has several other oncology programs in pivotal trials. Seagen also licenses its antibody-drug conjugate technology to several leading biotechnology and pharmaceutical companies.


Related Channels

YouTube Symbol Surfing

Watch these videos to learn how Symbol Surfing can increase your trading and investing knowledge and results.